NO20011829D0 - Oralt sertralinkonsentrat - Google Patents

Oralt sertralinkonsentrat

Info

Publication number
NO20011829D0
NO20011829D0 NO20011829A NO20011829A NO20011829D0 NO 20011829 D0 NO20011829 D0 NO 20011829D0 NO 20011829 A NO20011829 A NO 20011829A NO 20011829 A NO20011829 A NO 20011829A NO 20011829 D0 NO20011829 D0 NO 20011829D0
Authority
NO
Norway
Prior art keywords
concentrate
oral sertraline
sertraline
oral
sertraline concentrate
Prior art date
Application number
NO20011829A
Other languages
English (en)
Other versions
NO20011829L (no
Inventor
Nancy Jane Harper
Gautam Ramchandra Ranade
Willard Mckowan Welch
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22298286&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20011829(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20011829D0 publication Critical patent/NO20011829D0/no
Publication of NO20011829L publication Critical patent/NO20011829L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Reproductive Health (AREA)
  • Nutrition Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20011829A 1998-10-13 2001-04-10 Oralt sertralinkonsentrat NO20011829L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10402498P 1998-10-13 1998-10-13
PCT/IB1999/001571 WO2000021521A2 (en) 1998-10-13 1999-09-22 Sertraline oral concentrate

Publications (2)

Publication Number Publication Date
NO20011829D0 true NO20011829D0 (no) 2001-04-10
NO20011829L NO20011829L (no) 2001-06-05

Family

ID=22298286

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20011829A NO20011829L (no) 1998-10-13 2001-04-10 Oralt sertralinkonsentrat

Country Status (45)

Country Link
EP (1) EP1121107B1 (no)
JP (1) JP3792514B2 (no)
KR (1) KR100417200B1 (no)
CN (1) CN1184962C (no)
AP (1) AP2001002119A0 (no)
AR (1) AR014082A1 (no)
AT (1) ATE254453T1 (no)
AU (1) AU766202B2 (no)
BG (1) BG65085B1 (no)
BR (1) BR9914418A (no)
CA (1) CA2346335C (no)
CO (1) CO5150213A1 (no)
CZ (1) CZ20011286A3 (no)
DE (1) DE69912978T2 (no)
DK (1) DK1121107T3 (no)
DZ (1) DZ2913A1 (no)
EA (1) EA003990B1 (no)
EE (1) EE04868B1 (no)
EG (1) EG23818A (no)
ES (1) ES2209490T3 (no)
GC (1) GC0000175A (no)
GE (1) GEP20032969B (no)
GT (1) GT199900171A (no)
HK (1) HK1040199B (no)
HR (1) HRP20010263B1 (no)
HU (1) HUP0104470A3 (no)
ID (1) ID29845A (no)
IS (1) IS2239B (no)
MA (1) MA26698A1 (no)
MY (1) MY122477A (no)
NO (1) NO20011829L (no)
NZ (1) NZ510756A (no)
OA (1) OA11662A (no)
PA (1) PA8483301A1 (no)
PE (1) PE20001108A1 (no)
PL (1) PL348119A1 (no)
PT (1) PT1121107E (no)
SK (1) SK4582001A3 (no)
TN (1) TNSN99190A1 (no)
TR (1) TR200101090T2 (no)
TW (1) TWI228043B (no)
UA (1) UA72743C2 (no)
WO (1) WO2000021521A2 (no)
YU (1) YU26401A (no)
ZA (1) ZA200102900B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1671628B1 (en) 1999-09-03 2012-10-03 APBI Holdings, LLC Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
US20030086972A1 (en) * 2000-08-09 2003-05-08 Appel Leah E. Hydrogel-driven drug dosage form
WO2004065348A1 (en) * 2003-01-23 2004-08-05 Pfizer Products Inc. Pharmaceutically acceptable salts of sertraline and pharmaceutical compositions thereof
JP2007502329A (ja) * 2003-05-23 2007-02-08 トランスフォーム・ファーマシューティカルズ・インコーポレイテッド セルトラリン組成物
WO2005034910A1 (en) * 2003-10-08 2005-04-21 Ranbaxy Laboratories Limited Oral liquid pharmaceutical compositions of sertraline
WO2007052152A2 (en) * 2005-11-07 2007-05-10 Aurobindo Pharma Limited Sertraline oral concentrate
US20080268067A1 (en) * 2007-03-09 2008-10-30 Llinas Rodolfo R Methods and Compositions for Treating Thalamocortical Dysrhythmia
CN109908354A (zh) * 2017-12-12 2019-06-21 万特制药(海南)有限公司 盐酸舍曲林口服浓缩液及其制备工艺

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536518A (en) * 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
DE69004529T2 (de) * 1989-08-30 1994-02-24 Pfizer Verwendung von Sertralin zur Behandlung von Abhängigkeiten von chemischen Stoffen.
US4940731A (en) * 1989-08-30 1990-07-10 Pfizer Inc. Method of treating premature ejaculation using sertraline
US5130338A (en) * 1989-08-30 1992-07-14 Pfizer Inc. Method of treating chemical dependencies using sertraline
US4962128A (en) * 1989-11-02 1990-10-09 Pfizer Inc. Method of treating anxiety-related disorders using sertraline
CA2143070C (en) * 1994-02-22 2001-12-18 Pankaj Modi Oral controlled release liquid suspension pharmaceutical formulation
US5597826A (en) * 1994-09-14 1997-01-28 Pfizer Inc. Compositions containing sertraline and a 5-HT1D receptor agonist or antagonist
SE508372C2 (sv) * 1995-02-13 1998-09-28 Kjell Lindstroem Metod och utrustning för tillförsel eller aspiration av substanser inom gastrointestinalkanalen, avsedd för mätning av farmakokinetiska och fysikalisk-kemiska parametrar
ES2192217T3 (es) * 1995-07-17 2003-10-01 Pfizer Sertralina para el tratamiento de pacientes tras un infarto de miocardio.
UA68350C2 (en) * 1997-07-01 2004-08-16 Pfizer Prod Inc Dosage forms of encapsulated sertraline

Also Published As

Publication number Publication date
HK1040199A1 (en) 2002-05-31
OA11662A (en) 2004-12-08
NO20011829L (no) 2001-06-05
ZA200102900B (en) 2002-05-29
EP1121107B1 (en) 2003-11-19
ID29845A (id) 2001-10-18
ES2209490T3 (es) 2004-06-16
BR9914418A (pt) 2001-06-26
GEP20032969B (en) 2003-05-27
TR200101090T2 (tr) 2001-12-21
KR20010080096A (ko) 2001-08-22
IS5906A (is) 2001-03-23
DE69912978D1 (de) 2003-12-24
HRP20010263A2 (en) 2002-06-30
EE200100221A (et) 2002-08-15
CN1184962C (zh) 2005-01-19
PE20001108A1 (es) 2000-10-26
EP1121107A2 (en) 2001-08-08
BG65085B1 (bg) 2007-02-28
PL348119A1 (en) 2002-05-06
JP2002527385A (ja) 2002-08-27
EA200100285A1 (ru) 2001-10-22
EE04868B1 (et) 2007-08-15
MA26698A1 (fr) 2004-12-20
IS2239B (is) 2007-05-15
HRP20010263B1 (en) 2005-04-30
ATE254453T1 (de) 2003-12-15
WO2000021521A2 (en) 2000-04-20
CA2346335C (en) 2006-04-18
KR100417200B1 (ko) 2004-02-05
MY122477A (en) 2006-04-29
GC0000175A (en) 2006-03-29
CN1323202A (zh) 2001-11-21
SK4582001A3 (en) 2002-02-05
JP3792514B2 (ja) 2006-07-05
AR014082A1 (es) 2001-01-31
AU5643699A (en) 2000-05-01
PA8483301A1 (es) 2000-09-29
AP2001002119A0 (en) 2001-03-22
UA72743C2 (en) 2005-04-15
PT1121107E (pt) 2004-02-27
YU26401A (sh) 2005-07-19
EG23818A (en) 2007-09-19
CO5150213A1 (es) 2002-04-29
CA2346335A1 (en) 2000-04-20
NZ510756A (en) 2003-05-30
HK1040199B (zh) 2005-05-27
CZ20011286A3 (cs) 2001-09-12
HUP0104470A3 (en) 2003-12-29
WO2000021521A3 (en) 2000-07-20
TNSN99190A1 (fr) 2005-11-10
DE69912978T2 (de) 2004-04-22
TWI228043B (en) 2005-02-21
DK1121107T3 (da) 2004-02-23
EA003990B1 (ru) 2003-12-25
HUP0104470A2 (en) 2002-08-28
DZ2913A1 (fr) 2004-03-01
GT199900171A (es) 2001-03-28
AU766202B2 (en) 2003-10-09
BG105434A (en) 2001-12-29

Similar Documents

Publication Publication Date Title
ID26936A (id) Komposisi herbisida konsentrat
ID26720A (id) Komposisi oral
DE69912286D1 (de) Zahnbürste
DE69827672D1 (de) Teleskopartiges intraorales kraftelement
DE69934002D1 (de) Zahnbürste
DE69934771D1 (de) Zahnbürste
DE69920345D1 (de) Fräsmeissel
ATE217021T1 (de) Präparationsmittel
DK1121107T3 (da) Oralt sertralin-koncentrat
IS5260A (is) Uppleystar sertralín samsetningar
DE29805323U1 (de) Zahnbürste
DE29807736U1 (de) Zahnbürste
FI980856A0 (fi) Andningsskydd utrustad med en identifierare
IS5877A (is) Ný efnablanda
DE29900775U1 (de) Zahnbürste
DE29801586U1 (de) Kefirkonzentrat
DE29815083U1 (de) Milch-Überkochmelder
DE59907824D1 (de) Zahnbürste
IS5879A (is) Ný efnablanda
DE59901177D1 (de) Zahnbürste
DE29821443U1 (de) Zahnbürste
DE29819064U1 (de) Zahnbürste
SI1121107T1 (en) Sertraline oral concentrate
ATA208398A (de) Handstück
DE29811763U1 (de) Hygienecenter

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application